VACONTIL

This brand name is authorized in Cyprus, Hong Kong, Malta, Singapore

Active ingredients

The drug VACONTIL contains one active pharmaceutical ingredient (API):

1 Loperamide UNII 6X9OC3H4II - LOPERAMIDE

By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency. Read about Loperamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VACONTIL Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC
VACONTIL Capsule, hard	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 40800, 42905
Country: MT	Medicines Authority	Identifier(s): AA032/07201, AA032/07202
Country: SG	Health Sciences Authority	Identifier(s): 05587P